The pharmaceutical industry is rapidly evolving, with increasing demand for high-performance Active Pharmaceutical Ingredients (APIs). Dulaglutide, a GLP-1 receptor agonist, represents example of this trend. To https://thefairlist.com/story10629785/leading-us-based-dulaglutide-api-manufacturing-services